Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL4750734 | 0.78 | CYP2C19 (0.48) | TAAR1HIF1ATSHRCYP2C19ALDH1A1 | |
| SCHEMBL20135772 | 0.74 | TAAR1 (0.73) | TAAR1TSHRCYP2C19ALDH1A1NPC1 | |
| Bromide SCHEMBL2446042 | 0.74 | HIF1A (0.74) | HIF1ATSHRCYP2C19ALDH1A1CYP1A2 | |
| SCHEMBL20146704 | 0.74 | TAAR1 (0.73) | TAAR1TSHRCYP2C19ALDH1A1NPC1 | |
| Bromide SCHEMBL2449969 | 0.74 | HIF1A (0.74) | HIF1ATSHRCYP2C19ALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL1680771 | 0.74 | CYP2C19 (0.48) | TAAR1HIF1ATSHRCYP2C19ALDH1A1 | |
| SCHEMBL30963576 | 0.74 | TAAR1 (0.55) | TAAR1TSHRCYP2C19ALDH1A1NPC1 | |
| Iodide SCHEMBL3976020 | 0.74 | CYP2C19 (0.48) | TAAR1HIF1ATSHRCYP2C19ALDH1A1 | |
| SCHEMBL4729485 | 0.74 | TAAR1 (0.55) | TAAR1TSHRCYP2C19ALDH1A1ADRA2A | |
| SCHEMBL27346489 | 0.74 | CYP2C19 (0.62) | TAAR1TSHRCYP2C19ALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998005651-A1 | NOVEL GLUTAMATE RECEPTOR ANTAGONISTS: FUSED CYCLOALKYL QUINOXALINEDIONES | WARNER-LAMBERT COMPANY (US) | 1998-02-12 | — | — | WO | disclosed |